At week @ , further reductions with insulin titration resulted in changes from baseline in HbA@c of -@ @ % ( -@ @ mmol/mol ) , -@ @ % ( -@ @ mmol/mol ) , and -@ @ % ( -@ @ mmol/mol ) with placebo , empagliflozin @ mg , and empagliflozin @ mg , respectively , and final HbA@c of @ % ( @ mmol/mol ) , @ % ( @ mmol/mol ) , and @ % ( @ mmol/mol ) , respectively .